Advertisement
Screener

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

2.0 / 5 stars · 19/47 Roast Me

PROVECTUS BIOPHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 3.08 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-26

  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-12-31 was 0.00 shares.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-12-31 was 0.00 shares.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2021-12-31 was 0.00 shares.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2016-06-30 was 3.83M shares.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 3.08M shares, a 1950.00% increase from fiscal 2024.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 150.00K shares, a 25.00% decline from fiscal 2023.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 200.00K shares, a 0.00% change from fiscal 2022.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 200.00K shares, a 82.98% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in PeriodShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 0 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month
2025-12-313.08M shares
10-K · filed 2026-03-26
2024-12-31150.00K shares
10-K · filed 2025-03-28
2023-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28
200.00K shares
10-K · filed 2025-03-28
2023-09-30200.00K shares
10-Q · filed 2023-11-14
2022-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
200.00K shares
10-K · filed 2024-03-28
2022-09-30200.00K shares
10-Q · filed 2022-11-09
2021-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
1.18M shares
10-K · filed 2023-03-30
2021-09-301.18M shares
10-Q · filed 2021-11-10
2020-12-31725.00K shares
10-K · filed 2022-03-29
2019-12-31200.00K shares
10-K · filed 2021-03-02
2018-12-31150.00K shares
10-K · filed 2020-03-05
2017-12-31-150.00K shares
10-K · filed 2018-03-23
2016-12-31-7.13M shares
10-K · filed 2018-03-23
2016-06-303.83M shares
10-Q · filed 2016-11-09
2015-12-09400.00K shares
10-K · filed 2016-03-30
2015-05-2725.00K shares
10-Q · filed 2015-08-06
2015-02-26300.00K shares
10-Q · filed 2015-08-06
2015-01-07300.00K shares
10-Q · filed 2015-11-05
2014-05-2725.00K shares
10-Q · filed 2015-11-05
2014-02-26300.00K shares
10-Q · filed 2015-11-05
300.00K shares
10-K · filed 2016-03-30